Related Experiment Video
Updated: Sep 9, 2026

Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry (UPLC-HRMS)
Published on: May 20, 2013
The data substrate of exposome intelligence: an interoperability profile for untargeted metabolomics
1Doerenkamp-Zbinden Chair for Evidence-based Toxicology, Bloomberg School of Public Health and Whiting School of Engineering, Johns Hopkins University, Center for Alternatives to Animal Testing (CAAT), Baltimore, MD, United States.
Abstract:
Untargeted metabolomics, anchored in high-resolution mass spectrometry, has matured into the central analytical platform of human exposomics. It can capture endogenous biology, diet, drugs, microbial chemistry, environmental contaminants, and their transformation products from a single biological sample. Yet exposome science remains stubbornly single-study: most untargeted exposomics publications stand alone, featuring tables, partial annotations, and semi-quantitative intensities that cannot be combined across cohorts. The bottleneck is no longer instrumentation or annotation; it is interoperability. Existing standards, including MSI, mQACC, BP4NTA, NORMAN, MERIT, mzML, mzTab-M, ISA-Tab, the Universal Spectrum Identifier, RefMet, ChEBI, MetaboLights, Metabolomics Workbench, GNPS/MassIVE, and the emerging GA4GH human exposome data standards, cover the necessary ingredients but do not yet compose a single, executable profile. I argue that the next stage of exposomics must move from FAIR deposition to meta-analysis-ready evidence: a four-layer stack of acquisition comparability, machine-readable reporting, evidence-aware annotation, and standardized summary statistics, validated by a living community benchmark. Cumulative exposome science depends on it.

